Trial Profile
An open label phase II study of indisulam in combination with irinotecan in patients with metastatic colorectal cancer who have been previously treated with 5-fluorouracil/leucovorin [folinic acid] and oxaliplatin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2006
Price :
$35
*
At a glance
- Drugs Indisulam (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 12 Oct 2006 Status change
- 26 Nov 2005 New trial record.